New Drug Coming For Actinic Keratosis

The FDA has approved a new gel called ingenol mebutate in a treatment course that can be as short as 2 or 3 days for the treatment of actinic keratosis (AK). AK are commonly thought of as pre-cancers on the skin. Approximately 1 in 5 Americans will develop skin cancer, and approximately 65% of squamous carcinoid cancers begin as untreated AK.